Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study

Main Article Content

Jonathan I Silverberg
Nana Kragh
Emma Guttman-Yassky
Andreas Wollenberg



Abstract not available.


Disclosures: Study sponsored by LEO Pharma.


Copyright 2018 SKIN

Most read articles by the same author(s)

1 2 3 > >>